BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29246722)

  • 1. Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.
    Yu W; Tang C; Hobbs BP; Li X; Koay EJ; Wistuba II; Sepesi B; Behrens C; Rodriguez Canales J; Parra Cuentas ER; Erasmus JJ; Court LE; Chang JY
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1090-1097. PubMed ID: 29246722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis.
    Wu J; Aguilera T; Shultz D; Gudur M; Rubin DL; Loo BW; Diehn M; Li R
    Radiology; 2016 Oct; 281(1):270-8. PubMed ID: 27046074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer.
    Fave X; Zhang L; Yang J; Mackin D; Balter P; Gomez D; Followill D; Jones AK; Stingo F; Liao Z; Mohan R; Court L
    Sci Rep; 2017 Apr; 7(1):588. PubMed ID: 28373718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer.
    Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS
    Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Franceschini D; Cozzi L; De Rose F; Navarria P; Fogliata A; Franzese C; Pezzulla D; Tomatis S; Reggiori G; Scorsetti M
    Strahlenther Onkol; 2020 Oct; 196(10):922-931. PubMed ID: 31722061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer.
    Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z
    Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC.
    Dou TH; Coroller TP; van Griethuysen JJM; Mak RH; Aerts HJWL
    PLoS One; 2018; 13(11):e0206108. PubMed ID: 30388114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer.
    Huynh E; Coroller TP; Narayan V; Agrawal V; Hou Y; Romano J; Franco I; Mak RH; Aerts HJ
    Radiother Oncol; 2016 Aug; 120(2):258-66. PubMed ID: 27296412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer.
    Gu Q; Feng Z; Liang Q; Li M; Deng J; Ma M; Wang W; Liu J; Liu P; Rong P
    Eur J Radiol; 2019 Sep; 118():32-37. PubMed ID: 31439255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
    Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
    Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiomics for Survival Risk Stratification of Clinical and Pathologic Stage IA Pure-Solid Non-Small Cell Lung Cancer.
    Wang T; She Y; Yang Y; Liu X; Chen S; Zhong Y; Deng J; Zhao M; Sun X; Xie D; Chen C
    Radiology; 2022 Feb; 302(2):425-434. PubMed ID: 34726531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics Signature: A Biomarker for the Preoperative Distant Metastatic Prediction of Stage I Nonsmall Cell Lung Cancer.
    Fan L; Fang M; Tu W; Zhang D; Wang Y; Zhou X; Xia Y; Li Z; Liu S
    Acad Radiol; 2019 Sep; 26(9):1253-1261. PubMed ID: 30527455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage III Non-Small Cell Lung Cancer: Prognostic Value of FDG PET Quantitative Imaging Features Combined with Clinical Prognostic Factors.
    Fried DV; Mawlawi O; Zhang L; Fave X; Zhou S; Ibbott G; Liao Z; Court LE
    Radiology; 2016 Jan; 278(1):214-22. PubMed ID: 26176655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prognostic analysis method for non-small cell lung cancer based on the computed tomography radiomics.
    Wang X; Duan H; Li X; Ye X; Huang G; Nie S
    Phys Med Biol; 2020 Feb; 65(4):045006. PubMed ID: 31962301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer.
    Tang X; Xu X; Han Z; Bai G; Wang H; Liu Y; Du P; Liang Z; Zhang J; Lu H; Yin H
    Biomed Eng Online; 2020 Jan; 19(1):5. PubMed ID: 31964407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of pre-therapy 2-deoxy-2-
    Arshad MA; Thornton A; Lu H; Tam H; Wallitt K; Rodgers N; Scarsbrook A; McDermott G; Cook GJ; Landau D; Chua S; O'Connor R; Dickson J; Power DA; Barwick TD; Rockall A; Aboagye EO
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):455-466. PubMed ID: 30173391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
    Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
    Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cone-beam computed tomography-based delta-radiomics for early response assessment in radiotherapy for locally advanced lung cancer.
    Shi L; Rong Y; Daly M; Dyer B; Benedict S; Qiu J; Yamamoto T
    Phys Med Biol; 2020 Jan; 65(1):015009. PubMed ID: 31307024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
    Starkov P; Aguilera TA; Golden DI; Shultz DB; Trakul N; Maxim PG; Le QT; Loo BW; Diehn M; Depeursinge A; Rubin DL
    Br J Radiol; 2019 Feb; 92(1094):20180228. PubMed ID: 30457885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a venous computed tomography radiomics model to predict lymph node metastasis from non-small cell lung cancer.
    Cong M; Yao H; Liu H; Huang L; Shi G
    Medicine (Baltimore); 2020 May; 99(18):e20074. PubMed ID: 32358390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.